Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201802002761404Completed
Trial of tranexamic acid and etamsylate (3 arms), sponsored by PLA Air Force Characteristic Medical Center. Primary endpoint: Amount of blood loss. Started Dec 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201802002761404.